ALG13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.608200E-01
Normal-vs-Stage2
3.076600E-01
Normal-vs-Stage3
2.057400E-01
Normal-vs-Stage4
7.932600E-01
Stage1-vs-Stage2
6.062400E-02
Stage1-vs-Stage3
1.156020E-01
Stage1-vs-Stage4
9.015800E-01
Stage2-vs-Stage3
2.300200E-01
Stage2-vs-Stage4
7.198300E-02
Stage3-vs-Stage4
9.189900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.941800E-01
Normal-vs-AfricanAmerican
4.090400E-01
Normal-vs-Asian
4.417600E-01
Caucasian-vs-AfricanAmerican
8.124400E-01
Caucasian-vs-Asian
7.379400E-01
AfricanAmerican-vs-Asian
9.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.604960E-01
Normal-vs-Female
6.901400E-01
Male-vs-Female
1.486240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.741800E-01
Normal-vs-Age(41-60Yrs)
5.551200E-01
Normal-vs-Age(61-80Yrs)
3.280600E-01
Normal-vs-Age(81-100Yrs)
5.358800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.506200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.025800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.871200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.850300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.828200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.154800E-01
Normal-vs-Daily Drinker
1.931030E-01
Normal-vs-Weekly Drinker
5.266200E-01
Normal-vs-Occasional Drinker
8.022200E-01
Normal-vs-Social Drinker
7.218400E-01
Non Drinker-vs-Daily Drinker
4.633400E-01
Non Drinker-vs-Weekly Drinker
8.873200E-01
Non Drinker-vs-Occasional Drinker
2.007200E-01
Non Drinker-vs-Social Drinker
2.986800E-01
Daily Drinker-vs-Weekly Drinker
5.514000E-01
Daily Drinker-vs-Occasional Drinker
8.657800E-02
Daily Drinker-vs-Social Drinker
1.322190E-01
Weekly Drinker-vs-Occasional Drinker
4.302000E-01
Weekly Drinker-vs-Social Drinker
5.346600E-01
Occasional Drinker-vs-Social Drinker
8.604200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.158200E-02
Normal-vs-Grade 2
1.722470E-02
Normal-vs-Grade 3
7.012000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.079600E-01
Grade 1-vs-Grade 3
3.408200E-01
Grade 1-vs-Grade 4
9.158200E-02
Grade 2-vs-Grade 3
7.132400E-01
Grade 2-vs-Grade 4
1.722470E-02
Grade 3-vs-Grade 4
7.012000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.256550E-01
Normal-vs-NonDiabetic
4.407600E-01
Diabetic-vs-NonDiabetic
7.609900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.455800E-01
Normal-vs-NoPancreatitis
3.965000E-01
Pancreatitis-vs-NoPancreatitis
8.153600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.734800E-01
Normal-vs-N1
3.221600E-01
N0-vs-N1
5.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.065000E-01
Normal-vs-TP53-NonMutant
7.948800E-01
TP53-Mutant-vs-TP53-NonMutant
1.112810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
